IOPtima – Obtained regulatory approval for the sales and marketing of the IOPtiMate ™ system in Taiwan

BioLight announced today that on August 27, 2017,
IOPtima Ltd., a subsidiary of the Company, announced that it has received
regulatory approval from the Taiwan Ministry of Health (TFDA) for the sales and marketing
of the IOPtiMate ™ system of IOPtima, a CO2 laser assisted surgical system enabling
glaucoma surgery without penetrating the eye.

Link to complete article 

Link to Newsroom

Comments are closed